돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 4173생성일: 2026년 10월 24일

5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one → 5,11-Dihydro-11-[1-oxo-2-methyl-4-pentynyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one

https://huagongshe.com/ko/reaction/4173

반응식

참여 물질

역할이름HCID투입량
반응물5,11-Dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-oneHCID 70169—
반응물2-Methyl-4-pentynoic acid chlorideHCID 13924395—
반응물ButyllithiumHCID 178418339—
용매TetrahydrofuranHCID 8028—
용매HexaneHCID 8058—
용매Ethyl AcetateHCID 8857—
생성물5,11-Dihydro-11-[1-oxo-2-methyl-4-pentynyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-oneHCID 13729207—

반응 단계

At 0° to 10° C., with stirring, 416 ml (0.65 mol) of an n-butyl-lithium solution in n-hexane are added dropwise to a suspension of 63 g (0.3 mol) of 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one in 1500 ml of absolute tetrahydrofuran. THe mixture is stirred for a further hour at ambient temperature, then cooled to 5° to 10° C. and this temperature 46.8 g (0.36 mol) of 2-methyl-4-pentynoic acid chloride (not purified) dissolved in 100 ml of absolute tetrahydrofuran are added dropwise to the reaction solution. The mixture is stirred for a further 3 hours at ambient temperature, then added to 2000 ml of a saturated saline solution and diluted with about 2000 ml of ethyl acetate. The organic phase is separated off, extracted twice with 500 ml of saturated saline solution, dried over magnesium sulphate and evaporated to dryness in vacuo. The desired compound is obtained as a brownish-yellow product which is used without further purification in the next step.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US04724236
출처 데이터셋uspto-grants-1988_02
ORD IDord-909765aa47fa47b3808e7296f9f062de
출처 메모uspto-grants-1988_02